Asymmetric dimethyloarginin (ADMA) concentration in the aqueous humor of patients with exfoliation syndrome or exfoliative glaucoma

Simple item page
dc.contributor.authorMikropoulos, D. G.spa
dc.contributor.authorMallini, P.spa
dc.contributor.authorMichopoulou, A.spa
dc.contributor.authorGiannopoulos, T.spa
dc.contributor.authorArranz Márquez, Estherspa
dc.contributor.authorKoliakos, G. G.spa
dc.contributor.authorKonstas, A. G.spa
dc.date.accessioned2014-03-18T10:09:12Z
dc.date.available2014-03-18T10:09:12Z
dc.date.issued2013spa
dc.description.abstractAsymmetric dimethyloarginin or dimethylarginin (ADMA) is a marker and maker of oxidative stress. It is elevated in several pathological conditions, such as hyperhomocysteinemia and endothelial dysfunction, which have also been reported in patients with exfoliation syndrome (XFS), or exfoliative glaucoma (XFG). We evaluated ADMA levels in the aqueous humor of XFS and XFG patients.spa
dc.description.impact1.663 JCR (2013) Q3, 32/58 Ophtalmologyspa
dc.identifier.citationMikropoulos, D. G., Mallini, P., Michopoulou, A., Giannopoulos, T., Arranz-Márquez, E., Koliakos, G. G., & Konstas, A. G. (2013). Asymmetric dimethyloarginin (ADMA) concentration in the aqueous humor of patients with exfoliation syndrome or exfoliative glaucoma. Current Eye Research, 38(2), 266-270.spa
dc.identifier.doi10.3109/02713683.2012.757325spa
dc.identifier.issn14602202spa
dc.identifier.issn02713683spa
dc.identifier.urihttp://hdl.handle.net/11268/2119
dc.language.isoengspa
dc.peerreviewedSispa
dc.rights.accessRightsrestricted accessen
dc.subject.unescoOftalmologíaspa
dc.subject.unescoTratamiento médicospa
dc.titleAsymmetric dimethyloarginin (ADMA) concentration in the aqueous humor of patients with exfoliation syndrome or exfoliative glaucomaspa
dc.typejournal articlespa
dspace.entity.typePublication

Files

Collections

Área de Ciencias de la Salud